Showing 141 - 160 results of 17,049 for search '(((( auc largest decrease ) OR ( mri also increased ))) OR ( ((i larger) OR (a large)) decrease ))', query time: 0.91s Refine Results
  1. 141
  2. 142
  3. 143

    Capturing the Transient Microstructure of a Physically Assembled Gel Subjected to Temperature and Large Deformation by Rosa Maria Badani Prado (11501833)

    Published 2021
    “…Here, we report the real-time change in the structure of physically assembled triblock copolymer gels that consist of 10 and 20 wt % of poly­(styrene)–poly­(isoprene)–poly­(styrene) [PS–PI–PS] triblock copolymer in mineral oil (i) during the gelation process with decreasing temperature, (ii) subjected to large oscillatory deformation, and (iii) during the stress-relaxation process after the application of a step strain. …”
  4. 144

    Capturing the Transient Microstructure of a Physically Assembled Gel Subjected to Temperature and Large Deformation by Rosa Maria Badani Prado (11501833)

    Published 2021
    “…Here, we report the real-time change in the structure of physically assembled triblock copolymer gels that consist of 10 and 20 wt % of poly­(styrene)–poly­(isoprene)–poly­(styrene) [PS–PI–PS] triblock copolymer in mineral oil (i) during the gelation process with decreasing temperature, (ii) subjected to large oscillatory deformation, and (iii) during the stress-relaxation process after the application of a step strain. …”
  5. 145
  6. 146
  7. 147

    Triple B←N Lewis Pair-Functionalized Triazatruxenes with Large Stokes Shifts by Yufeng Zhang (195768)

    Published 2023
    “…The introduction of B←N Lewis pairs not only results in a large decrease in the HOMO–LUMO gap but also lowers the LUMO to −3.00 eV. …”
  8. 148
  9. 149
  10. 150
  11. 151
  12. 152

    Table_3_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  13. 153

    Table_5_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  14. 154

    Table_7_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  15. 155

    Table_2_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  16. 156

    Table_4_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  17. 157

    Table_6_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  18. 158

    Table_1_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  19. 159
  20. 160